126 related articles for article (PubMed ID: 38251649)
21. Are large thyroid nodules classified as benign on fine needle aspiration more likely to harbor cancer?
Shi H; Bobanga I; McHenry CR
Am J Surg; 2017 Mar; 213(3):464-466. PubMed ID: 28057295
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules).
Carty SE; Ohori NP; Hilko DA; McCoy KL; French EK; Manroa P; Morariu E; Sridharan S; Seethala RR; Yip L
Ann Surg; 2020 Oct; 272(4):621-627. PubMed ID: 32773640
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.
Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW
JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952
[TBL] [Abstract][Full Text] [Related]
24. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
Siddiqui MA; Griffith KA; Michael CW; Pu RT
Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
[TBL] [Abstract][Full Text] [Related]
25. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
26. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
27. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS/FLUS Thyroid Nodules.
Remer LF; Linhares SM; Scola WH; Lew JI
J Surg Res; 2023 Sep; 289():229-233. PubMed ID: 37148856
[TBL] [Abstract][Full Text] [Related]
28. BRAF V600 co-testing is technically feasible in conventional thyroid fine needle aspiration (FNA) cytology smears and can reduce the need for completion thyroidectomy.
Poller DN; Glaysher S
Cytopathology; 2014 Jun; 25(3):155-9. PubMed ID: 24164374
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
[TBL] [Abstract][Full Text] [Related]
30. Fine needle aspiration of thyroid nodules. Determinants of insufficiency rate and malignancy yield at thyroidectomy.
Burch HB; Burman KD; Reed HL; Buckner L; Raber T; Ownbey JL
Acta Cytol; 1996; 40(6):1176-83. PubMed ID: 8960025
[TBL] [Abstract][Full Text] [Related]
31. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules.
Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI
J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733
[TBL] [Abstract][Full Text] [Related]
32. ThyroSeq
Rivas AM; Nassar A; Zhang J; Casler JD; Chindris AM; Smallridge R; Bernet V
Endocr Pract; 2018 Sep; 24(9):780-788. PubMed ID: 30084677
[TBL] [Abstract][Full Text] [Related]
33. INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION.
Dinan MA; Li Y; Reed SD; Sosa JA
Endocr Pract; 2019 Jan; 25(1):31-42. PubMed ID: 30383499
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of fine-needle aspiration biopsy of thyroid nodules in males.
Schiro AJ; Pinchot SN; Chen H; Sippel RS
J Surg Res; 2010 Apr; 159(2):645-50. PubMed ID: 19932905
[TBL] [Abstract][Full Text] [Related]
35. Why Did the Rapid Increase of Reflex Molecular Testing of Indeterminate Fine Needle Aspiration Cytologies in the USA Not Impact Thyroidectomy Rates? What Is the Lesson to Be Learned?
Paschke R
Thyroid; 2024 Mar; 34(3):290-291. PubMed ID: 38343362
[No Abstract] [Full Text] [Related]
36. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study.
Espinosa De Ycaza AE; Lowe KM; Dean DS; Castro MR; Fatourechi V; Ryder M; Morris JC; Stan MN
Thyroid; 2016 Nov; 26(11):1598-1604. PubMed ID: 27549368
[TBL] [Abstract][Full Text] [Related]
37. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules.
Schumm MA; Nguyen DT; Kim J; Tseng CH; Chow AY; Shen N; Livhits MJ
Ann Surg Oncol; 2021 Dec; 28(13):8872-8881. PubMed ID: 34292427
[TBL] [Abstract][Full Text] [Related]
39. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
[TBL] [Abstract][Full Text] [Related]
40. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
De Napoli L; Bakkar S; Ambrosini CE; Materazzi G; Proietti A; Macerola E; Basolo F; Miccoli P
Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]